Doctor taking notes

Resources

Publications

Jun 2024
Results of a Phase 2b multicenter randomized trial of larsucosterol for the treatment of severe alcohol-associated hepatitis (AHFIRM Trial)
Mitchell L. Shiffman, Ben Da, Lance Stein, Christophe Moreno, Ashwini Mehta, Alexandre Louvet, Amanda J. Nicoll, Aparna Goel, Allison Kwong, Steven Flamm, Sanjaya Satapathy, Alexander Kuo, Nikolaos Pyrsopoulos, Daniel Ganger, Costica Aloman, Simone Strasser, Eddie Tse, Mark Russo, Don Rockey, Meagan Gray, Mack Mitchell, Mark Thursz, William Krebs, Deborah Scott, Christina Blevins, James Brown, WeiQi Lin, Norman Sussman | The European Association for the Study of the Liver (EASL) International Liver Congress
Aug 2023
Epidemic within a pandemic: Alcohol-associated hepatitis and COVID-19
Natalie Marlowe, David Lam, Suthat Liangpunsakul | Alcohol: Clinical and Experimental Research (ACER)
Jun 2023
Epidemic Within Pandemic: Alcohol-Related Hepatitis and COVID-19
Natalie Marlowe, David Lam, Suthat Liangpunsakul | The European Association for the Study of the Liver (EASL) International Liver Congress
Apr 2023
Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis
Tarek Hassanein, Craig J. McClain, Vatsalya Vatsalya, Lance L. Stein, Steven L. Flamm, Paul Martin, Matthew C. Cave, Mack Mitchell Jr, Bruce Barton, Laura Nagy, Gyongyi Szabo, Arthur McCullough, Srinivasin Dasarathy, Jaymin Shah, Christina Blevins, Deborah Scott, William Krebs, James E. Brown, WeiQi Lin  | The American Journal of Gastroenterology
Mar 2023
Alcohol-associated Hepatitis as a Secondary Diagnosis: Comparisons of Medicare Patient Outcomes and Hospital Financial Performance, 2017-2019
Natalie Marlowe, Robert C. Saunders, Clarisa Peer, Keith Lui, Julia Sheriff, Lane Koenig, Norman Sussman | AMCP

Factsheets

See the resources included here for more information and resources from DURECT.

Scroll to Top